相关实验视频

Updated: Jun 9, 2025

Proteomic Analysis of Human Macrophage Polarization Under a Low Oxygen Environment

Proteomic Analysis of Human Macrophage Polarization Under a Low Oxygen Environment

Published on: January 7, 2019

TP53 Codon 72 多态性影响通过反应性氧物种-依赖细胞信号改变对巨细胞激活

Ashok Silwal¹, Britney Reese¹, Bhaumik Patel¹

¹Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX.

Journal of immunology (Baltimore, Md. : 1950)

|October 25, 2024

概括

这是一个TP53基因.

科学领域:

免疫学免疫学免疫学
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

在TP53基因的共同单核酸多态性 (SNP) 在代码子72影响免疫调节.
TP53的R72和P72变体对巨细胞激活和炎症反应有明显的影响.

研究的目的:

调查TP53编码子72SNP在免疫系统调节中的作用,特别是在COVID-19和巨细胞激活中.
阐明TP53变种影响细胞信号通路和免疫细胞表型的分子机制.

主要方法:

与免疫反应相关的TP53SNP变体 (R72和P72) 的分析.
研究R72-p53对线粒体超氧化物脱酶和PTEN活性的影响.
检查TP53变异对PI3K/Akt通路激活和巨细胞极化 (M1/M2) 的影响.
使用癌症和内毒性病的小鼠模型来评估P72和R72巨细胞的体内功能.

主要成果:

在COVID-19患者中,R72变异通过偏向的巨细胞激活促进了加剧的炎症反应.
R72-p53抑制了超氧化物脱酶,导致PTEN氧化和PI3K/Akt路径激活,有利于M2巨细胞.
P72巨细胞维持M1表型,减少瘤生长,并增强抗瘤T细胞反应.
在内毒性病模型中,P72巨细胞也增加了死亡率.

结论:

TP53编码子72 SNP显著影响巨细胞激活,影响炎症和抗瘤反应.
由TP53 SNP驱动的细胞信号的变化可能会导致健康差异,特别是在P72频率高的人群中,如非洲裔美国人.
了解这些遗传影响对于解决涉及失调巨细胞激活的疾病的健康差异至关重要.

更多相关视频

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...